GPCR
Structure TherapeuticsrGPCR
$16.35-5.92%24H
GPCR / USDNASDAQ
Use arrow keys to change the interval
NAV$87.04
Liquidity—
Holders1
Circulating Supply5.32
Chains
ProviderReality Finance
P/E Ratio—
Market Cap$1.24B
EPS-3.72
52 Week Range$16.30 – $94.90
Volume$13.23M
Other Issuers—
NameStructure Therapeutics
TickerrGPCR
DividendsNo
Asset ClassStocks
Redemption Fees0.00%
Subscription Fees0.00%
IssuerReality Finance
Custodian—
Crypto Custodian—
Inception—
DomicileEl Salvador
Resolution Country—
About Structure Therapeutics Inc. American Depositary Shares

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. The company is headquartered in South San Francisco, California.

HeadquartersSOUTH SAN FRANCISCO, CA

Buy

—
—
Trending
SPCXB
SpaceX
$127.967.39%
Details
FXIon
iShares China Large-Cap ETF
$31.241.78%
Details
ANTB
Anthropic
$88.438.70%
Details

Help